Search research articles
Contact Us
Filters
Showing results (1-10 of 84) with videos related to
Page
of 9
Sort By:
ESMO Open
|
September 27, 2019
B7x-from bench to bedside
Gurbakhash Kaur, Murali Janakiram
Cardiovascular & Hematological Disorders Drug Targets
|
July 4, 2012
Current and emerging therapies in primary myelofibrosis
Sabarish Ayyappan, Murali Janakiram, Radha Raghupathy
Trends in Cancer
|
July 6, 2024
Targeting cancer stem cells in multiple myeloma
Emine Gulsen Gunes, Metin Gunes, Jianhua Yu, et al.
Transplantation and Cellular Therapy
|
October 11, 2021
Novel Cell and Immune Engagers in Optimizing Tumor- Specific Immunity Post-Autologous Transplantation in Multiple Myeloma
Murali Janakiram, Nivedita Arora, Veronika Bachanova, et al.
Current Treatment Options in Oncology
|
February 3, 2012
Emerging Therapeutic Targets in Diffuse Large B-Cell Lymphoma
Murali Janakiram, Venu K Thirukonda, Matthew Sullivan, et al.
Discovery Medicine
|
November 2, 2012
T cell coinhibition and immunotherapy in human breast cancer
Murali Janakiram, Yael M Abadi, Joseph A Sparano, et al.
Thrombosis
|
December 19, 2013
A systematic review of the utility of residual vein obstruction studies in primary and secondary venous thrombosis
Murali Janakiram, Matthew Sullivan, Marina Shcherba, et al.
Immunotherapy
|
June 29, 2016
Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies
Murali Janakiram, Vipul Pareek, Haiying Cheng, et al.
Future Oncology (London, England)
|
March 18, 2025
Establishing a successful outpatient CAR T-Cell program with cilta-cel: real-world experience from an expert roundtable
Melissa Alsina, Binod Dhakal, Jeremy Pantin, et al.
Oncoimmunology
|
September 26, 2015
HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families
Murali Janakiram, Jordan M Chinai, Aimin Zhao, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 84) with videos related to
Sort By:
Page
of 9
ESMO Open
|
September 27, 2019
B7x-from bench to bedside
Gurbakhash Kaur, Murali Janakiram
Cardiovascular & Hematological Disorders Drug Targets
|
July 4, 2012
Current and emerging therapies in primary myelofibrosis
Sabarish Ayyappan, Murali Janakiram, Radha Raghupathy
Trends in Cancer
|
July 6, 2024
Targeting cancer stem cells in multiple myeloma
Emine Gulsen Gunes, Metin Gunes, Jianhua Yu, et al.
Transplantation and Cellular Therapy
|
October 11, 2021
Novel Cell and Immune Engagers in Optimizing Tumor- Specific Immunity Post-Autologous Transplantation in Multiple Myeloma
Murali Janakiram, Nivedita Arora, Veronika Bachanova, et al.
Current Treatment Options in Oncology
|
February 3, 2012
Emerging Therapeutic Targets in Diffuse Large B-Cell Lymphoma
Murali Janakiram, Venu K Thirukonda, Matthew Sullivan, et al.
Discovery Medicine
|
November 2, 2012
T cell coinhibition and immunotherapy in human breast cancer
Murali Janakiram, Yael M Abadi, Joseph A Sparano, et al.
Thrombosis
|
December 19, 2013
A systematic review of the utility of residual vein obstruction studies in primary and secondary venous thrombosis
Murali Janakiram, Matthew Sullivan, Marina Shcherba, et al.
Immunotherapy
|
June 29, 2016
Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies
Murali Janakiram, Vipul Pareek, Haiying Cheng, et al.
Future Oncology (London, England)
|
March 18, 2025
Establishing a successful outpatient CAR T-Cell program with cilta-cel: real-world experience from an expert roundtable
Melissa Alsina, Binod Dhakal, Jeremy Pantin, et al.
Oncoimmunology
|
September 26, 2015
HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families
Murali Janakiram, Jordan M Chinai, Aimin Zhao, et al.
Page
of 9